Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel diseaseVAN ASSCHE, Gert; RUTGEERTS, Paul.American journal of physiology. Gastrointestinal and liver physiology. 2005, Vol 51, Num 2, pp G169-G174, issn 0193-1857Article

Medical management of postoperative recurrence in Crohn's diseaseVAN ASSCHE, Gert; RUTGEERTS, Paul.Gastroenterology clinics of North America. 2004, Vol 33, Num 2, issn 0889-8553, x, 347-360 [15 p.]Article

Rôle de la cicatrisation muqueuse dans les MICIVAN ASSCHE, Gert; VERMEIRE, Séverine; RUTGEERTS, Paul et al.Hépato-gastro (Montrouge). 2008, Vol 15, Num JUIN, pp 20-25, issn 1253-7020, 6 p., NSArticle

Influence of long-term administration of lactulose and Saccharomyces Boulardii on the colonic generation of phenolic compounds in healthy human subjectsDE PRETER, Vicky; COOPMANS, Tamara; RUTGEERTS, Paul et al.Journal of the American College of Nutrition. 2006, Vol 25, Num 6, pp 541-549, issn 0731-5724, 9 p.Article

Management of acute severe ulcerative colitisVAN ASSCHE, Gert; VERMEIRE, Séverine; RUTGEERTS, Paul et al.Gut. 2011, Vol 60, Num 1, pp 130-133, issn 0017-5749, 4 p.Article

Mucosal healing in inflammatory bowel diseuse : impossible ideal or therapeutic target?RUTGEERTS, Paul; VERMEIRE, Severine; VAN ASSCHE, Gert et al.Gut. 2007, Vol 56, Num 4, pp 453-455, issn 0017-5749, 3 p.Article

Non-variceal upper gastrointestinal bleedingSIMOENS, Marc; RUTGEERTS, Paul.Baillière's best practice & research. Clinical gastroenterology. 2001, Vol 15, Num 1, pp 121-133, issn 1521-6918Article

Influence of resistant starch alone or combined with wheat bran on gastric emptying and protein digestion in healthy volunteersDE PRETER, Vicky; CLOETENS, Lieselotte; RUTGEERTS, Paul et al.Scandinavian journal of gastroenterology. 2007, Vol 42, Num 10, pp 1187-1193, issn 0036-5521, 7 p.Article

Infliximab therapy for patients with inflammatory bowel disease: 10 years onVAN ASSCHE, Gert; VERMEIRE, Séverine; RUTGEERTS, Paul et al.European journal of pharmacology. 2009, Vol 623, issn 0014-2999, S17-S25, NSArticle

Does the biomarker ¹⁵N-lactose ureide allow to estimate the site of fermentation of resistant starch?CLOETENS, Lieselotte; DE PRETER, Vicky; DE LOOR, Henriette et al.European journal of nutrition (Print). 2008, Vol 47, Num 4, pp 217-223, issn 1436-6207, 7 p.Article

Tc-99m HMPAO white blood cell scintigraphy in the assessment of the extent and severity of an acute exacerbation of Ulcerative colitisBENNINK, Roelof; PEETERS, Marc; D'HAENS, Geert et al.Clinical nuclear medicine. 2001, Vol 26, Num 2, pp 99-104, issn 0363-9762Article

The yield of upper gastrointestinal Endoscopy in Patients with suspected reflux-related chronic ear, nose, and throat symptomsPOELMANS, Johan; FEENSTRA, Louw; DEMEDTS, Ingrid et al.The American journal of gastroenterology. 2004, Vol 99, Num 8, pp 1419-1426, issn 0002-9270, 8 p.Article

Switch to adalimumab in patients with Crohn's disease controlled by maintenance infliximab: prospective randomised SWITCH trialVAN ASSCHE, Gert; VERMEIRE, Séverine; RUTGEERTS, Paul et al.Gut. 2012, Vol 61, Num 2, pp 229-234, issn 0017-5749, 6 p.Article

High-throughput method for comparative analysis of denaturing gradient gel electrophoresis profiles from human fecal samples reveals significant increases in two bifidobacterial species after inulin-type prebiotic intakeJOOSSENS, Marie; HUYS, Geert; VAN STEEN, Kristel et al.FEMS microbiology ecology. 2011, Vol 75, Num 2, pp 343-349, issn 0168-6496, 7 p.Article

Mucosal Gene Expression of Cell Adhesion Molecules, Chemokines, and Chemokine Receptors in Patients With I nflammatory Bowel Disease Before and After Infliximab TreatmentARIJS, Ingrid; DE HERTOGH, Gert; SCHUIT, Frans et al.The American journal of gastroenterology. 2011, Vol 106, Num 4, pp 748-761, issn 0002-9270, 14 p.Article

Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel diseaseMOMOZAWA, Yukihide; MNI, Myriam; FINKEL, Yigael et al.Nature genetics. 2011, Vol 43, Num 1, pp 43-47, issn 1061-4036, 5 p.Article

Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitisHENCKAERTS, Liesbet; JASPERS, Martine; CUPPENS, Harry et al.Journal of hepatology. 2009, Vol 50, Num 1, pp 150-157, issn 0168-8278, 8 p.Article

Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unitHENCKAERTS, Liesbet; NIELSEN, Kaspar R; VERMEIRE, Séverine et al.Critical care medicine. 2009, Vol 37, Num 1, pp 192-201, issn 0090-3493, 10 p.Article

Detection of Anti synthetic Mannoside Antibodies (AΣMA) Reveals Heterogeneity in the ASCA Response of Crohn's Disease Patients and Contributes to Differential Diagnosis, Stratification, and PredictionVANDEWALLE-EL KHOURY, Peggy; COLOMBEL, Jean-Frederic; TARGAN, Stephan R et al.The American journal of gastroenterology. 2008, Vol 103, Num 4, pp 949-957, issn 0002-9270, 9 p.Article

Certolizumab pegol for the treatment of crohn's diseaseSANDBORN, William J; FEAGAN, Brian G; STOINOV, Simeon et al.The New England journal of medicine. 2007, Vol 357, Num 3, pp 228-238, issn 0028-4793, 11 p.Article

Immunosuppressive activity of a new pteridine derivative (4AZA1378) alleviates severity of TNBS-induced colitis in miceCHONG SHEN; DILLISSEN, Ellen; RUTGEERTS, Paul et al.Clinical immunology (Orlando, Fla. Print). 2007, Vol 122, Num 1, pp 53-61, issn 1521-6616, 9 p.Article

Long- term effectiveness of azathioprine in IBD beyond 4 years : A european multicenter study in 1176 patientsHOLTMANN, Martin H; KRUMMENAUER, Frank; DUCHMANN, Rainer et al.Digestive diseases and sciences. 2006, Vol 51, Num 9, pp 1516-1524, issn 0163-2116, 9 p.Article

Infliximab for induction and maintenance therapy for ulcerative colitisRUTGEERTS, Paul; SANDBORN, William J; DE VILLIERS, Willem J. S et al.The New England journal of medicine. 2005, Vol 353, Num 23, pp 2462-2476, issn 0028-4793, 15 p.Article

Autoimmunity associated with anti-tumor necrosis factor a treatment in Crohn's disease: A prospective cohort studyVERMEIRE, Severine; NOMAN, Maja; VAN ASSCHE, Gert et al.Gastroenterology (New York, NY. 1943). 2003, Vol 125, Num 1, pp 32-39, issn 0016-5085, 8 p.Article

VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic deathLAMBRECHTS, Diether; STORKEBAUM, Erik; AL-CHALABI, Ammar et al.Nature genetics. 2003, Vol 34, Num 4, pp 383-394, issn 1061-4036, 12 p.Article